Cardiovascular safety of psychedelic medicine: current status and future directions
Psychedelics are powerful psychoactive substances that alter perception and mood processes. Their effectiveness in the treatment of psychiatric diseas…
Psychedelic-Assisted Group Therapy: A Systematic Review
Abstract:
Contemporary research with classic psychedelic drugs (e.g., lysergic acid diethylamide (LSD) and psilocybin) is indebted to the twentieth-ce…
Adults who microdose psychedelics report health related motivations and lower levels of anxiety and depression compared to non-microdosers
The use of psychedelic substances at sub-sensorium ‘microdoses’, has gained popular academic interest for reported positive effects on wellness and co…
Adverse events in clinical treatments with serotonergic psychedelics and MDMA: A mixed-methods systematic review
Introduction
Small-scale clinical studies with psychedelic drugs have shown promising results for the treatment of several mental disorders. Before ps…
Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences
Psilocybin and lysergic acid diethylamide (LSD) experiences can range from very positive to highly challenging (e.g., fear, grief, and paranoia). Thes…
Using a MDMA- and LSD-Group Therapy Model in Clinical Practice in Switzerland and Highlighting the Treatment of Trauma-Related Disorders
The Swiss Federal Act on Narcotics allows for the restricted medical use of scheduled psychotropic drugs in cases of resistance to standard treatment,…
Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants
Mescaline, lysergic acid diethylamide (LSD), and psilocybin are classic serotonergic psychedelics. A valid, direct comparison of the effects of these …
The therapeutic potential of microdosing psychedelics in depression
Rationale
Microdosing psychedelics is the repeated use of small doses of, for example, lysergic acid diethylamide (LSD) and psilocybin, typically for …
The Use of Classic Hallucinogens/Psychedelics in a Therapeutic Context: Healthcare Policy Opportunities and Challenges
Psychedelics or serotonergic hallucinogens are a group of substances that share the agonism of serotonergic 5-HT2A receptors as their main mechanism o…
LSD and psilocybin for chronic nociplastic pain: A narrative review of the literature supporting the use of classic psychedelic agents in chronic pain
Healthcare providers face the challenging task of managing patients who suffer from chronic nociplastic pain conditions. Pain is a …